Modulation of neurotransmitter action: control of the gamma- aminobutyric acid response through the benzodiazepine receptor
Open accessThe DOI matches its Crossref record.
Abstract
The ability of several homologous benzodiazepine and heterologous nonbenzodiazepine ligands to alter the conductance increase induced in spinal cord neurons by gamma-aminobutyric acid (GABA) was determined. Complete dose-response curves were carried out on individual neurons, reducing error introduced by cell-to-cell variability. The efficacies of modulation differ for “classical” benzodiazepines and novel nonbenzodiazepine drugs in a manner consistent with a model of control of GABA receptor action through a common receptor. There was no apparent correlation between efficacy and potency. CL 218,872, a triazolopyridazine, gave the lowest efficacy of the tranquilizers tested. Ro 15–1788 (an imidazobenzodiazepine) potentiated g GABA with high potency and low efficacy, consistent with an action as a partial agonist and an “antagonist” of classical benzodiazepine action. In order of increasing efficacy, Ro 15–1788, CL 218,872, and flurazepam are partial agonists, whereas clonazepam, chlordiazepoxide, diazepam, and flunitrazepam are full agonists. The beta-carboline drugs methyl- beta-carboline-3-carboxylate (beta-CCM) and methyl-6,7-dimethoxy-4- ethyl-beta-carboline-3-carboxylate (DMCM) are “anxiogenics” and convulsants that were found to exert through the benzodiazepine receptor-inhibitory and apparently insurmountable control of g GABA . beta-CCM and DMCM display large negative efficacies and act like effectors at a site distinct from the picrotoxin-sensitive chloride ionophore and coincident with the benzodiazepine site. The actions of these different benzodiazepine receptor ligands in vivo range from anxiolytic and anticonvulsant to anxiogenic and convulsant. Efficacy rather than potency almost certainly determines the qualitative nature of the pharmacological actions of these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
From ion currents to genomic analysis: Recent advances in GABAA receptor research
Rabow, L. E., Russek, S. J., & Farb, D. H. (1995) · Synapse · doi:10.1002/syn.890210302 · Cited by 475
Self-citationNovel anxiolytics that act as partial agonists at benzodiazepine receptors
Haefely, W., Martin, J. R., & Schoch, P. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90126-s · Cited by 276
17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors
Weaver, C. E., Park-Chung, M., Gibbs, T. T., & Farb, D. H. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00449-6 · Cited by 275
Self-citationFriedman, L. K., Gibbs, T. T., & Farb, D. H. (1996) · Brain Research · doi:10.1016/0006-8993(95)01226-5 · Cited by 69
Self-citationTargeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders
Farb, D. H., & Ratner, M. H. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009126 · Cited by 55
Self-citation
Metadata
- Authors
- Chan, C., & Farb, D.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1985-09-01
- Volume
- 5
- Issue
- 9
- Pages
- 2365-2373
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2104877311
- Cited by
- 122
- References
- 0
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulation of neurotransmitter action: control of the gamma- aminobutyric acid response through the benzodiazepine receptor. https://app.cochat.ai/papers/10.1523/jneurosci.05-09-02365.1985
- The paper
- Chan, C., & Farb, D. (1985). Modulation of neurotransmitter action: control of the gamma- aminobutyric acid response through the benzodiazepine receptor. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.05-09-02365.1985
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.